Coadministration has not been studied. Nebivolol metabolism involves CYP2D6. Darunavir/cobicistat could potentially increase nebivolol concentrations although to a limited extent as cobicistat is a weak inhibitor of CYP2D6. No a priori dosage adjustment is recommended.